-+ 0.00%
-+ 0.00%
-+ 0.00%

Upstream Bio Announces Top-Line Results from Phase 2 VALIANT Trial of Verekitug in Severe Asthma

Reuters·02/10/2026 23:00:11

Please log in to view news